Above products are not available in patent covered areas, or only used for laboratory research and development.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Roxadustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor (<strong>HIF-PHI</strong>) used to treat anemia in chronic kidney disease. Its core synthesis involves complex heterocyclic construction. <strong>Molecular Formula</strong>: C<sub>18</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub>; <strong>CAS No.</strong>: 1279650-28-8.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical manufacturing for erythropoiesis-stimulating agents.</li>
<li>Treatment of anemia associated with chronic kidney disease (CKD).</li>
<li>Research into novel therapies for hypoxic conditions.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in patients with uncontrolled hypertension. Store in a cool, dry place below 25°C. Handle with PPE due to potential toxicity during industrial processing.</p>